Showing 8721-8730 of 18131 results for "".
- Emerging Tick-Borne Pathogen: Jingmen Tick Virus Detected in Italyhttps://reachmd.com/news/emerging-tick-borne-pathogen-jingmen-tick-virus-detected-in-italy/2485005/Jingmen tick virus RNA was detected across multiple regions of Italy, a finding with immediate implications for clinicians assessing tick-exposed patients and for public-he
- Biomarkers in Action: Angiopoietin-2's Role in Post-Injury Pneumoniahttps://reachmd.com/news/biomarkers-in-action-angiopoietin-2s-role-in-post-injury-pneumonia/2485008/Angiopoietin-2 identifies burn patients at higher short-term risk for pneumonia when elevated on post-burn day 2–3; in the reported cohort, those elevations
- Role-Switching in Alveolar Macrophages: Implications for Allergic Airway Diseasehttps://reachmd.com/news/role-switching-in-alveolar-macrophages-implications-for-allergic-airway-disease/2485011/Alveolar macrophage plasticity enables lung-resident macrophages to flip from homeostatic guardians into active drivers of allergic airway inflammation, reframing mechanistic understanding and identifying cell-directed therapeutic targets.
- Inflammation Pathway Blockade Offers New Hope in Cirrhosis Managementhttps://reachmd.com/news/inflammation-pathway-blockade-offers-new-hope-in-cirrhosis-management/2485013/Blocking the PAF pathway reduced structural liver injury and improved hepatic vascular function in preclinical models of cirrhosis, acc
- Sustaining Trauma Quality Improvement in Ghana: Evidence from a Clinical Trialhttps://reachmd.com/news/sustaining-trauma-quality-improvement-in-ghana-evidence-from-a-clinical-trial/2484994/In a randomized trial across eight non-tertiary hospitals in Ghana, a structured trauma quality-improvement program anchored by a standardized trauma int
- Advancements in Retinal Therapeutics: Insights from the TALON Phase IIIb Studyhttps://reachmd.com/news/advancements-in-retinal-therapeutics-insights-from-the-talon-phase-iiib-study/2484990/The TALON trial demonstrates that a treat‑and‑extend regimen using a longer‑acting anti‑VEGF can materially reduce injection frequency and patient burden in neovascular AMD; crucially,
- Ultrasensitive Liquid Biopsies: A New Paradigm in Immunotherapy Monitoring and Predictionhttps://reachmd.com/news/ultrasensitive-liquid-biopsies-a-new-paradigm-in-immunotherapy-monitoring-and-prediction/2484997/Investigators at Vall d'Hebron Institute of Oncology report that an ultrasen
- High-Dose Rifampicin Shows No Survival Benefits in Tuberculous Meningitis: Clinical Implicationshttps://reachmd.com/news/high-dose-rifampicin-shows-no-survival-benefits-in-tuberculous-meningitis-clinical-implications/2484988/Radboud University Medical Center and international partners tested whether adding a higher oral rifampicin dose to standard four-drug therapy would reduce deaths in adults with tuberculous meningitis in the randomized
- Surveillance and Resistance Patterns of Healthcare-Associated Infections in the WHO African Region: Implications for Stewardshiphttps://reachmd.com/news/surveillance-and-resistance-patterns-of-healthcare-associated-infections-in-the-who-african-region-implications-for-stewardship/2484989/A systematic review of 95 studies (2011–2024) across the WHO African Region finds that fragmented healthcare-associated infection (HAI) surveillance produces substantial uncertainty in regional
- New Insights on Nemolizumab: Rapid Itch Relief and Sleep Improvementhttps://reachmd.com/news/nemolizumab-rapid-itch-relief-sleep-improvement/2484969/Post-hoc analyses of the ARCADIA and OLYMPIA programs show clinically meaningful itch reduction and parallel sleep improvement measurable within 48 hours. ARCADIA enrolled pa